Autologous Vaccination With Lethally Irradiated, Autologous Breast Cancer Cells Engineered to Secrete GM-CSF in Women With Operable Breast Cancer
Clinical trial NCT00880464 · COMPLETED
Trial details
- NCT number
- NCT00880464
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2011-10-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.